Post-radiation increase in VEGF enhances glioma cell motility in vitro

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Kil, Whoon J ^a   Tofilon, Philip J ^a   Camphausen, Kevin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Glioma cell; Motility; Radiation; VEGF

Indexed keywords

FOCAL ADHESION KINASE; MESSENGER RNA; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CANCER INVASION; CELL CULTURE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIATION RESPONSE; SIGNAL TRANSDUCTION; BRAIN TUMOR; CELL ADHESION; CELL MOTION; CULTURE MEDIUM; DRUG ANTAGONISM; GENETICS; GLIOMA; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; GLIOMA; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84858442412     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-25     Document Type: Article

References (34)

1. Stupp R, Hegi ME, van den Bent MJ, Mason WP, Weller M, Mirimanoff RO, Cairncross JG. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group: Changing paradigms-an update on the multidisciplinary management of malignant glioma. Oncologist 2006, 11(2):165-180. 10.1634/theoncologist.11-2-165, 16476837.
2. Matsukado Y, MacCarty CS, Kernohan JW. The growth of glioblastoma multiforme in neurosurgical practice. J Neurosurg 1961, 18:636-644. 10.3171/jns.1961.18.5.0636, 13768222.
3. Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980, 30(9):907-911.
4. Burger PC, Dubois P, Schold SC, Smith KR, Odom GL, Crafts DC, Giangaspero F. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent gliombastoma multiforme. J Neurosurg 1983, 58:159-169. 10.3171/jns.1983.58.2.0159, 6294260.
5. Gridley DS, Loredo LN, Slater JD, Archambeau JO, Bedros AA, Andres ML, Slater JM. Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor. Cancer Detect Prev 1988, 22(1):20-29.
6. Kim JH, Chung YG, Kim CY, Kim HK, Lee HK. Upregulation of VEGF and FGF2 in normal rat brain after experimental intraoperative radiation therapy. J Korean Med Sci 2004, 19:879-886. 10.3346/jkms.2004.19.6.879, 2816293, 15608402.
7. Salmaggi A, Eoli M, Frigerio S, Silvani A, Gelati M, Corsini E, Broggi G, Boiardi A. Intracavitary VEGF, bFGF, IG-8, IL-12 levels in primary and recurrent malignant glioma. J Neurooncol 2003, 62:297-303. 10.1023/A:1023367223575, 12777082.
8. Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW, Weichselbaum RR. Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 1999, 59:3374-3378.
9. Hiratsuka S, Watanbe A, Aburatani H, Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 2006, 8(12):1369-1375. 10.1038/ncb1507, 17128264.
10. Lesslie DP, Summy JM, Parikh NU, Fan F, Trevino JG, Sawuer TK, Metcalf CA, Shakespeare WC, Hicklin DJ, Ellis LM, Gallick GE. Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases. Br J Cancer 2006, 94:1710-1717. 2361330, 16685275.
11. Munshi N, Groopman JE, Gill PS, Ganju RK. c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells. J Immunol 2000, 164:1169-1174.
12. Jane EP, Remkumer DR, Pllack IF. Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells. J Pharmacol Exp Ther 2006, 319(3):1070-1080. 10.1124/jpet.106.108621, 16959960.
13. Timoshenko AV, Rastogi S, Lala PK. Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells. Br J Cancer 2007, 97:1090-1098. 10.1038/sj.bjc.6603993, 2360449, 17912247.
14. Chicoine MR, Silbergeld DL. Mitogens as motogens. J Neurooncol 1997, 35:249-257. 10.1023/A:1005808315821, 9440023.
15. Pore N, Liu S, Hass-Kogan DA, O'Rourke DM, Maity A. PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter. Cancer Res 2003, 63:236-241.
16. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438(7069):820-827. 10.1038/nature04186, 2945882, 16341007.
17. Matsumoto T, Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 2001, 112(21):1-17.
18. Guo D, Jia Q, Song HY, Warren RS, Donner DB. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. J Biol Chem 1995, 270:6729-6733. 10.1074/jbc.270.12.6729, 7896817.
19. Abedi H, Zachary I. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 1997, 272:2221-2230.
20. Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, Aggarwa B, Liu M. Acetyl-11keto-β-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res 2009, 69(14):5893-5900. 10.1158/0008-5472.CAN-09-0755, 2724674, 19567671.
21. Le Boeuf F, Houle F, Huot J. Regulation of vascular endothelial growth factor receptor 2-mediated phosphorylation of focal adhesion kinase by heat shock protein 90 and Src kinase activities. J Biol Chem 2004, 279(37):39175-39185. 10.1074/jbc.M405493200, 15247219.
22. Abu-Ghazaleh R, Kabir J, Jia H, Lobo M, Zachary I. Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells. Biochem J 2001, 360:255-264. 10.1042/0264-6021:3600255, 1222225, 11696015.
23. Shi Q, Hjelmeland A, Keir S, Song L, Wickman S, Jackson D, Ohmori O, Bigner D, Friedman H, Rich J. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226 inhibits glioma growth. Mol Carcinog 2007, 46:488-496. 10.1002/mc.20297, 17219439.
24. Xu B, Kim ST, Lim DS, Kastan MB. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell Biol 2002, 22(4):1049-59. 10.1128/MCB.22.4.1049-1059.2002, 134638, 11809797.
25. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 1988, 333:560-562. 10.1038/333560a0, 3287176.
26. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996, 87(8):3336-3343.
27. Muraoka RS, Dumont N, Ritter CA, Dugger TC, Brantley DM, Chen J, Easterly E, Roebuck LR, Ryan S, Gotwals PJ, Koteliansky V, Arteaga CL. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastasis. J Clin Invest 2002, 109(12):1551-1559. 151012, 12070302.
28. Westermark B, Magnusson A, Heldin C. Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cell. J Neurosci Res 1982, 8:491-507. 10.1002/jnr.490080236, 6296418.
29. Damiano V, Melisi D, Bianco C, Raben D, Caputo R, Fontanini G, Bianco R, Ryan A, Bianco R, Placido SD, Ciardiello F, Tortora G. Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma. Clin Cancer Res 2005, 11:5639-5644. 10.1158/1078-0432.CCR-05-0174, 16061883.
30. Damiano V, Melisi D, Bianco C, Raben D, Caputo R, Fontanini G, Bianco R, Ryan A, Bianco A, De Placido S, Ciardiello F, Tortora G. Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma. Clin Cancer Res 2005, 11(15):5639-5644. 10.1158/1078-0432.CCR-05-0174, 16061883.
31. Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR, Ellis LM. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 1997, 132:541-546. 10.1001/archsurg.1997.01430290087018, 9161399.
32. McLean GW, Fincham VJ, Frame MC. v-Src induces tyrosine phosphorylation of focal adhesion kinase independently of tyrosine 397 and formation of a complex with Src. J Biol Chem 2000, 275(30):23333-23339. 10.1074/jbc.M909322199, 10816598.
33. Obara S, Nakata M, Takeshima H, Kuratsu J, Maruyama I, Kitajima I. Inhibition of migration of human glioblastoma cells by cerivastatin in association with focal adhesion kinase (FAK). Cancer Lett 2002, 185(2):153-161. 10.1016/S0304-3835(02)00278-1, 12169389.
34. Calalb MB, Polte TR, Hanks SK. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 1995, 15(2):954-963. 231984, 7529876.